Agilon Health, Inc. (NYSE:AGL – Get Free Report) was the target of unusually large options trading activity on Tuesday. Traders bought 3,810 call options on the company. This is an increase of 187% compared to the typical daily volume of 1,328 call options.
Agilon Health Stock Performance
Agilon Health stock opened at $2.17 on Thursday. Agilon Health has a 1 year low of $1.50 and a 1 year high of $7.73. The firm’s 50-day moving average is $3.17 and its 200-day moving average is $3.20. The company has a market cap of $897.44 million, a P/E ratio of -3.67 and a beta of 0.14.
Agilon Health (NYSE:AGL – Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.04. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same quarter last year, the company posted ($0.02) earnings per share. Agilon Health’s revenue was down 4.5% on a year-over-year basis. As a group, sell-side analysts predict that Agilon Health will post -0.59 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
AGL has been the subject of several recent analyst reports. Sanford C. Bernstein upgraded Agilon Health from a “market perform” rating to an “outperform” rating and raised their target price for the company from $3.30 to $8.50 in a research note on Tuesday, April 8th. Citigroup raised Agilon Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $3.25 to $5.00 in a report on Friday, April 25th. Cowen restated a “hold” rating on shares of Agilon Health in a report on Tuesday, April 15th. Barclays raised their price target on shares of Agilon Health from $2.00 to $3.00 and gave the stock an “underweight” rating in a research report on Thursday, May 8th. Finally, Needham & Company LLC restated a “hold” rating on shares of Agilon Health in a research note on Friday, March 21st. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $4.79.
Get Our Latest Analysis on AGL
About Agilon Health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than Agilon Health
- Consumer Discretionary Stocks Explained
- Chime’s Smart IPO: Half the Valuation, Double the Strength
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks
- The Basics of Support and Resistance
- 3 Catalysts in 7 Days: Archer’s Growth Story Just Accelerated
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.